about
Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3GMolecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA.Identification of domains in apobec-1 complementation factor required for RNA binding and apolipoprotein-B mRNA editingApo E structure determines VLDL clearance and atherosclerosis risk in mice.Transglycosylation: a mechanism for RNA modification (and editing?).An AU-rich sequence element (UUUN[A/U]U) downstream of the edited C in apolipoprotein B mRNA is a high-affinity binding site for Apobec-1: binding of Apobec-1 to this motif in the 3' untranslated region of c-myc increases mRNA stability.The role of the LDL receptor in apolipoprotein B secretion.Human luteinized granulosa cells secrete apoB100-containing lipoproteins.Innate immune complexity in the purple sea urchin: diversity of the sp185/333 system.Transfer of plastid RNA-editing activity to novel sites suggests a critical role for spacing in editing-site recognition.Message therapy: gene therapy that targets mRNA sequence and stability.Phylogenetic analysis of the apolipoprotein B mRNA-editing region. Evidence for a secondary structure between the mooring sequence and the 3' efficiency element.APOBEC-1 and AID are nucleo-cytoplasmic trafficking proteins but APOBEC3G cannot trafficRegulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting.Measurement of fasting serum apoB-48 levels in normolipidemic and hyperlipidemic subjects by ELISA.Two efficiency elements flanking the editing site of cytidine 6666 in the apolipoprotein B mRNA support mooring-dependent editing.
P2860
Q21146408-ABAA1D2A-E08C-4BB2-860B-AE0601BF77A2Q22253163-8650BFC0-9BF8-44A5-AAAE-C7AFA093A345Q24292384-B5EB8FB9-6C48-4353-A590-46389BC16C1DQ30322098-4226ED94-3AA8-433A-B6BC-CA8E951C11F1Q33573979-2C697B95-7013-4AC9-8C38-01D7F08A1EA8Q33786932-EF7DB1F4-2E9F-4D09-A29F-24EF0E4BFBBEQ33939089-581B0940-8128-4FC5-9A6A-92C9E53F526FQ33993193-AD8DA177-4E18-4EAF-A345-A2B129E4D065Q35928281-B4BE0FB8-7D19-4EBD-884A-677317373BA5Q36332318-C614E465-7FEF-405E-8F5F-34BE76DB04D6Q41650542-6055D96F-89D8-4D48-9B97-D445139AA585Q41704284-460A8E58-6CF9-45F3-8383-3782B4B5F423Q42861821-1188D431-A720-4303-86DD-71C60339F79AQ43002584-B8480069-4A3C-4CED-AB70-4B3D1BC76E56Q44387529-C7393F75-1089-4751-8BAB-BA3C6BFF5088Q46625530-520BD2CA-17D5-4699-B8EE-CB9C6394E8CD
P2860
description
1997 nî lūn-bûn
@nan
1997 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մարտին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Apobec-1 and apolipoprotein B mRNA editing
@ast
Apobec-1 and apolipoprotein B mRNA editing
@en
Apobec-1 and apolipoprotein B mRNA editing
@nl
type
label
Apobec-1 and apolipoprotein B mRNA editing
@ast
Apobec-1 and apolipoprotein B mRNA editing
@en
Apobec-1 and apolipoprotein B mRNA editing
@nl
prefLabel
Apobec-1 and apolipoprotein B mRNA editing
@ast
Apobec-1 and apolipoprotein B mRNA editing
@en
Apobec-1 and apolipoprotein B mRNA editing
@nl
P2093
P1476
Apobec-1 and apolipoprotein B mRNA editing
@en
P2093
P356
10.1016/S0005-2760(96)00156-7
P407
P577
1997-03-10T00:00:00Z